| Control n = 7 | IGF-I/BP-3 n = 17 |
---|---|---|
Age (yrs) | 5.7 ± 1.1 | 6.2 ± 0.8 |
Gender (F/M) | 4/3 | 10/7 |
Body weight (kg) | 25 ± 3 | 27 ± 4 |
Height (cm) | 109 ± 11 | 118 ± 6 |
TBSA-burn (%) | 59 ± 4 | 55 ± 4 |
3rd degree-burn (%) | 46 ± 6 | 46 ± 6 |
Mortality (%) | 17 | 0 |
Study periods | Â | Â |
Hospital admission (days postburn) | 7 ± 2 | 7 ± 3 |
Start of study period I (days postburn) | 12 ± 3 | 14 ± 3 |
End of study period I (days postburn) | 17 ± 3 | 19 ± 3 |
Start of study period II (days postburn) | 24 ± 4 | 28 ± 3 |
End of study period II (days postburn) | 29 ± 4 | 33 ± 3 |